Chemical Compound

Hexanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-

CAS Registry Number 94885-02-6
Hexanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)- 结构式
Primary record

Hexanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-

库存
3,603 克
纯度
98.3 %
CAS
94885-02-6

化合物标识与属性

CAS
94885-02-6
PubChem CID
16219783
SMILES
CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)NC(=O)CCCCCNC1=CC=C(C2=NON=C12)[N+](=O)[O-])O
Canonical SMILES
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCNc1ccc([N+](=O)[O-])c2nonc12

名称与同义词

  • C6 NBD Ceramide
  • Nbd-ceramide
  • C6-Nbd-ceramide
  • C-6 NBD Ceramide
  • C6-Nbd-cer
  • NBD-C 6Cer
  • C6-NBD Ceramide
  • NBD C6-Ceramide
  • NBD-C6-Cer
  • 94885-02-6
  • NBD hexanoic ceramide
  • 39ZCU6EB2E
  • RefChem:1091364
  • CHEBI:59429
  • Epitope ID:131179
  • UNII-39ZCU6EB2E
  • N-(NBD-Aminohexanoyl)sphingosine
  • C30H49N5O6
  • CHEMBL135464
  • orb2278606
  • SCHEMBL16216321
  • N-(NBD-Aminohexanoyl) D-erythro-Sphingosine
  • N-C6-NBD-D-erythro-Sphingosine
  • DTXSID501334180
  • C6 NBD Ceramide (d18:1/6:0)
  • NBD Cer(18:1/2:0)
  • MFCD00467024
  • ZINC43380062
  • C30-H49-N5-O6
  • HY-W356116
  • ?C6 NBD Ceramide (d18:1/6:0)
  • N-(Nbd-aminohexanoyl)-D-erythro-sphingosine
  • DA-51517
  • CS-0467369
  • FT-0629299
  • NS00016772
  • Hexanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
  • J1.229.291K
  • J2.581.172K
  • G77040
  • N-{6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl}sphingosine
  • 86701-10-2
  • N-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine
  • Q27126704
  • N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanamide
  • 6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosine
  • N-[6-[(7-Nitrobenzofurazane-4-yl)amino]hexanoyl]sphingosine
  • N-([7-Nitrobenz-2-oxa-1,3-diazol-4-yl]aminocaproyl)sphingosine
  • N-(6-((7-Nitro-2-1,3-benzoxadiazol-4-yl)amino)hexanoyl)-D-erythro-sphingosine
  • N-[(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)aminocaproyl]sphingosine
  • (6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosine)
  • Hexanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)-
  • N-((1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)hexanamide
  • N-(6-((7-nitro-2,1,3-benzoxadiazol-4-yl)amino)hexanoyl)sphingosine
  • N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
  • N-[6-[(7-Nitro-2,1,3-benzooxadiazole-4-yl)amino]hexanoyl]sphingosine
  • N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine
  • (2S,3R)-2-[6-[(7-Nitro-2,1,3-benzooxadiazole-4-yl)amino]hexanoylamino]-4-octadecene-1,3-diol
  • Hexanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-
  • N-((E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl)-6-((4-nitro-2,1,3-benzoxadiazol-7-yl)amino)hexanamide
  • N-[(1S,2R,3E)-1-(Hydroxymethyl)-2-hydroxy-3-heptadecenyl]-6-(7-nitrobenzofurazane-4-ylamino)hexanamide
  • N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
  • N-[(2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
  • N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanamide
  • N-[(E,1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadec-3-enyl]-6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanamide